FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4377220043> ?p ?o ?g. }

• W4377220043 abstract "Stroke is a leading cause of disability with limited effective interventions that improve recovery in the subacute phase. This protocol aims to evaluate the safety and efficacy of a non-invasive, extremely low-frequency, low-intensity, frequency-tuned electromagnetic field treatment [Electromagnetic Network Targeting Field (ENTF) therapy] in reducing disability and promoting recovery in people with subacute ischemic stroke (IS) with moderate-severe disability and upper extremity (UE) motor impairment. Following a sample-size adaptive design with a single interim analysis, at least 150 and up to 344 participants will be recruited to detect a 0.5-point (with a minimum of 0.33 points) difference on the modified Rankin Scale (mRS) between groups with 80% power at a 5% significance level. This ElectroMAGnetic field Ischemic stroke–Novel subacutE treatment (EMAGINE) trial is a multicenter, double-blind, randomized, sham-controlled, parallel two-arm study to be conducted at approximately 20 United States sites, and enroll participants with subacute IS and moderate-severe disability with UE motor impairment. Participants will be assigned to active (ENTF) or sham treatment, initiated 4–21 days after stroke onset. The intervention, applied to the central nervous system, is designed for suitability in multiple clinical settings and at home. Primary endpoint is change in mRS score from baseline to 90 days post-stroke. Secondary endpoints: change from baseline to 90 days post-stroke on the Fugl-Meyer Assessment - UE (lead secondary endpoint), Box and Block Test, 10-Meter Walk, and others, to be analyzed in a hierarchical manner. EMAGINE will evaluate whether ENTF therapy is safe and effective at reducing disability following subacute IS. Trial registration www.ClinicalTrials.gov , NCT05044507 (14 September 2021)." @default.
• W4377220043 created "2023-05-23" @default.
• W4377220043 creator A5013051967 @default.
• W4377220043 creator A5018530459 @default.
• W4377220043 creator A5029578889 @default.
• W4377220043 creator A5029975016 @default.
• W4377220043 creator A5043283447 @default.
• W4377220043 creator A5047927654 @default.
• W4377220043 creator A5075359983 @default.
• W4377220043 creator A5083931095 @default.
• W4377220043 date "2023-05-05" @default.
• W4377220043 modified "2023-10-18" @default.
• W4377220043 title "EMAGINE–Study protocol of a randomized controlled trial for determining the efficacy of a frequency tuned electromagnetic field treatment in facilitating recovery within the subacute phase following ischemic stroke" @default.
• W4377220043 cites W1497431575 @default.
• W4377220043 cites W1576998361 @default.
• W4377220043 cites W1839661069 @default.
• W4377220043 cites W1969661146 @default.
• W4377220043 cites W1977086599 @default.
• W4377220043 cites W1978895122 @default.
• W4377220043 cites W1998855961 @default.
• W4377220043 cites W2012080190 @default.
• W4377220043 cites W2020074777 @default.
• W4377220043 cites W2026950175 @default.
• W4377220043 cites W2048935051 @default.
• W4377220043 cites W2051777375 @default.
• W4377220043 cites W2057403992 @default.
• W4377220043 cites W2069776382 @default.
• W4377220043 cites W2075808979 @default.
• W4377220043 cites W2084521665 @default.
• W4377220043 cites W2088709366 @default.
• W4377220043 cites W2099864518 @default.
• W4377220043 cites W2105322474 @default.
• W4377220043 cites W2118893727 @default.
• W4377220043 cites W2119418414 @default.
• W4377220043 cites W2120778013 @default.
• W4377220043 cites W2124804777 @default.
• W4377220043 cites W2129865987 @default.
• W4377220043 cites W2136361599 @default.
• W4377220043 cites W2139540288 @default.
• W4377220043 cites W2260584015 @default.
• W4377220043 cites W2277258071 @default.
• W4377220043 cites W2343101712 @default.
• W4377220043 cites W2346795597 @default.
• W4377220043 cites W2396720381 @default.
• W4377220043 cites W2497828341 @default.
• W4377220043 cites W2562019354 @default.
• W4377220043 cites W2605712511 @default.
• W4377220043 cites W2625474800 @default.
• W4377220043 cites W2735474392 @default.
• W4377220043 cites W2754229858 @default.
• W4377220043 cites W2756394066 @default.
• W4377220043 cites W2794265807 @default.
• W4377220043 cites W2895650339 @default.
• W4377220043 cites W2982682705 @default.
• W4377220043 cites W3003299879 @default.
• W4377220043 cites W3005719222 @default.
• W4377220043 cites W3126934616 @default.
• W4377220043 cites W3198977157 @default.
• W4377220043 cites W4230151929 @default.
• W4377220043 cites W4308974443 @default.
• W4377220043 doi "https://doi.org/10.3389/fneur.2023.1148074" @default.
• W4377220043 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37213907" @default.
• W4377220043 hasPublicationYear "2023" @default.
• W4377220043 type Work @default.
• W4377220043 citedByCount "1" @default.
• W4377220043 countsByYear W43772200432023 @default.
• W4377220043 crossrefType "journal-article" @default.
• W4377220043 hasAuthorship W4377220043A5013051967 @default.
• W4377220043 hasAuthorship W4377220043A5018530459 @default.
• W4377220043 hasAuthorship W4377220043A5029578889 @default.
• W4377220043 hasAuthorship W4377220043A5029975016 @default.
• W4377220043 hasAuthorship W4377220043A5043283447 @default.
• W4377220043 hasAuthorship W4377220043A5047927654 @default.
• W4377220043 hasAuthorship W4377220043A5075359983 @default.
• W4377220043 hasAuthorship W4377220043A5083931095 @default.
• W4377220043 hasBestOaLocation W43772200431 @default.
• W4377220043 hasConcept C126322002 @default.
• W4377220043 hasConcept C127413603 @default.
• W4377220043 hasConcept C168563851 @default.
• W4377220043 hasConcept C1862650 @default.
• W4377220043 hasConcept C203092338 @default.
• W4377220043 hasConcept C2776361831 @default.
• W4377220043 hasConcept C2778818304 @default.
• W4377220043 hasConcept C2780645631 @default.
• W4377220043 hasConcept C2780931571 @default.
• W4377220043 hasConcept C3020199598 @default.
• W4377220043 hasConcept C535046627 @default.
• W4377220043 hasConcept C541997718 @default.
• W4377220043 hasConcept C61943457 @default.
• W4377220043 hasConcept C71924100 @default.
• W4377220043 hasConcept C78519656 @default.
• W4377220043 hasConcept C99508421 @default.
• W4377220043 hasConceptScore W4377220043C126322002 @default.
• W4377220043 hasConceptScore W4377220043C127413603 @default.
• W4377220043 hasConceptScore W4377220043C168563851 @default.
• W4377220043 hasConceptScore W4377220043C1862650 @default.
• W4377220043 hasConceptScore W4377220043C203092338 @default.
• W4377220043 hasConceptScore W4377220043C2776361831 @default.
• W4377220043 hasConceptScore W4377220043C2778818304 @default.
• W4377220043 hasConceptScore W4377220043C2780645631 @default.

• next